Literature DB >> 19962938

Use of sodium oxybate (Xyrem in patients with dual diagnosis of narcolepsy and sleep apnea.

Ruzica Kovacević-Ristanović, Tomasz J Kuźniar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19962938     DOI： 10.1016/j.sleep.2009.09.001

Source DB:  PubMed          Journal:  Sleep Med        ISSN： 1389-9457            Impact factor:   3.492


× No keyword cloud information.
  3 in total

1.  Catathrenia under sodium oxybate in narcolepsy with cataplexy.

Authors:  Francesca Poli; Lara Ricotta; Stefano Vandi; Christian Franceschini; Fabio Pizza; Vincenzo Palaia; Keivan Kaveh Moghadam; Donatella Banal; Roberto Vetrugno; Michael J Thorpy; Giuseppe Plazzi
Journal:  Sleep Breath       Date:  2011-04-12       Impact factor: 2.816

2.  Further research on Xyrem®/sodium oxybate treatment of patients with obstructive sleep apnea is needed.

Authors:  Deborah L Zvosec; Stephen W Smith; Mark W Mahowald
Journal:  Sleep Breath       Date:  2010-09-18       Impact factor: 2.816

Review 3.  A practical guide to the therapy of narcolepsy and hypersomnia syndromes.

Authors:  Emmanuel J M Mignot
Journal:  Neurotherapeutics       Date:  2012-10       Impact factor: 7.620
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.